{"id":201565,"name":"WTPPG ON BEHALF OF ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS & INNOVATION","slug":"wtppg-on-behalf-of-alliance-for-biopharmaceutical-competitiveness-innovation","state":"DC","country":"United States of America","description":"tax consulting","totalSpending":80000,"filings":5,"yearlySpending":[{"year":2018,"income":80000},{"year":2019,"income":0}],"issues":["TAX"],"firms":["JAHANIAN STRATEGIES LLC"],"lobbyists":["NOUSHIN JAHANIAN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Treasury, Dept of"],"sampleDescriptions":["issues related to corporate and international tax reform including, IRC section 965, anti-base erosion provisions, foreign derived intangible income, tax treatment of U.S. sales, and global intangible","issues related to corporate and international tax reform including, IRC section 965, anti-base erosion provisions, foreign derived intangible income, tax treatment of U.S. sales, and global intangible","issues related to corporate and international tax reform including, IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174 and  965. Issues related to Puerto Rico incentives and excise taxes","issues related to corporate and international tax reform including, IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174 and  965. Issues related to Puerto Rico incentives and excise taxes"],"years":[2018,2019]}